Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Levamisole hydrochloride ; Rafoxanide
Biochem Ltd
QP52AE51
Levamisole hydrochloride ; Rafoxanide
15,22.5 milligram(s)/millilitre
Oral suspension
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Sheep
levamisole, combinations
Endoparasiticide
Authorised
1999-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Levafluke Oral Drench. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Oral Suspension. A yellow aqueous suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _LEVAFLUKE_ is a combination product for the treatment of the common nematode parasites (including lung worm - _Dicytocaulus_ spp.) and liver fluke (_Fasciola hepatica_) in cattle and sheep. _Levafluke_ is active against _Fasciola hepatica, (mature and immature over 8 weeks of age)_ _Nematodirus spp.,_ _Dictyocaulus spp.,_ _Ostertagia spp._ in cattle and sheep (except inhibited ostertagia larvae)_._ 4.3 CONTRAINDICATIONS Do not use in concurrent treatment with organophosphates and/or diethylcarbamazine. Do not use in animals with known hypersensitivity to the active ingredients. ACTIVE SUBSTANCE QUANTITY PER ML Rafoxanide 22.5 mg Levamisole Hydrochloride 15.0 mg EXCIPIENTS Methyl Parahydroxybenzoate (E218) 1.0 mg Propyl Parahydroxybenzoate (E216) 0.1 mg Sodium metabisulphite (E223) 0.2 mg Quinoline yellow (E104) 0.09 mg I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _6_ _/_ _0_ _4_ _/_ _2_ _0_ _1_ _3_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _4_ _5_ _8_ _7_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of developm Прочитайте повний документ